Ratings NEOS AB

Equities

NEOD

SE0021615655

Market Closed - Nasdaq Stockholm 12:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
0.9 SEK -0.22% Intraday chart for NEOS AB +2.04% -59.09%

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • One of the major weak points of the company is its financial situation.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
-59.09% 2.77M -
-33.70% 14.31B
A
-57.92% 2.1B
C+
+22.96% 1.95B -
-23.94% 1.28B -
+19.67% 1.21B
B+
+1.10% 779M -
-37.32% 748M -
-37.03% 720M -
C-
-29.95% 596M
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes